Monthly Rebound of 70%, 3 Institutions Filed for ETFs: Deconstructing the Data Truth Behind INJ's Surge
The cryptocurrency INJ has surged approximately 70% over the past month, with a 23% spike on October 16th. This rally is largely driven by a strategic shift towards institutional compliance and real-world asset (RWA) integration.
Injective's CEO recently held high-level meetings in Washington D.C. with officials from the White House, SEC, and CFTC. This follows a series of significant developments: the project's entity secured a crucial SEC-registered Transfer Agent license in August, three major institutions (21Shares, Canary Capital, REX-Osprey) filed for INJ spot and staking ETFs with the SEC, and Canadian mortgage giant Pineapple Financial (now Pentiv) announced plans to tokenize $10 billion in real estate loans on the Injective chain. A key governance proposal (IIP-709) also aims to implement fixed gas fees for exchange operations, appealing to institutional market makers.
While the project highlights a leading "Protocol Revenue/FDV" ratio (0.95) as a sign of being undervalued, analysis reveals this stems more from INJ's market cap collapsing over 85% from its peak, rather than exceptionally high revenue. Its annual on-chain protocol revenue is roughly $6 million, far below giants like Ethereum or Solana. Furthermore, despite a buyback-and-burn mechanism, the Proof-of-Stake chain's inflationary token issuance may outpace the deflationary impact.
The surge appears to be a classic "old coin, new narrative" play: leveraging a small, oversold market cap with a compelling story of regulatory progress and institutional adoption. The short-term momentum may continue, but investors are advised to monitor on-chain metrics like holdings and whale activity, as the fundamental revenue picture remains relatively modest.
marsbit20 saat önce
